早期皮质缩与神经病理学证实帕金森病患者的抑郁症有关
Emmilotta A Backman1, Laura Luntamo1, Riitta Parkkola2
1Clinical Neurosciences, University of Turku, Turku, Finland; Neurocenter, Turku University Hospital, Turku, Finland.
Journal of the neurological sciences
|November 22, 2023
概括
帕金森症的抑郁症与中部时和全球皮质缩有关. 这种大脑缩似乎在抑郁症患者中进展得更快.
科学领域:
- 神经学 神经学
- 神经成像是一种神经成像.
- 老年病的医生 老年病的医生
背景情况:
- 抑郁症经常与帕金森病 (PD) 和其他同核蛋白病变同时发生.
- 以前,皮质缩与老年患者没有PD的抑郁症有关.
研究的目的:
- 调查皮质缩,白质高强度 (WMHs) 和尸检确认的帕金森症患者的临床抑郁症之间的关联.
- 为了探索大脑结构变化是否在抑郁症患者和非抑郁症帕金森症患者之间有所不同.
主要方法:
- 利用50名帕金森症患者 (30名PD,10名PSP,10名MSA) 的计算机断层扫描 (CT) 来自动分析使用卷积神经网络的中部缩 (MTA),全球皮质缩 (GCA) 和WMH.
- 从患者档案中分析了包括抑郁症在内的临床数据,其中19名患者接受了第二次扫描以进行纵向评估.
主要成果:
- 抑郁症与MTA和GCA的增加显著相关,即使在对诊断,年龄,症状持续时间和认知进行控制后也是如此.
- 这些关联仅仅在帕金森病患者中对MTA保持显著.
- 纵向分析显示,与非抑郁患者相比,抑郁患者每年GCA进展的速度更快.
结论:
- 自动化CT图像分析表明,早期的中间时和全球皮质缩与帕金森症的临床抑郁症有关.
- 全球皮质缩似乎在患有帕金森症的抑郁个体中进展得更快.
更多相关视频
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
1.6K
08:29Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
14.1K
相关概念视频
Parkinson's Disease: Overview
560
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
560
Parkinson's Disease: Treatment
278
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
278
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Alzheimer's Disease: Overview
496
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
496
Depression: Overview
254
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
254
